For instance, FOXP1 upregulation reveals a poor outcome in diffuse large B-cell lymphoma [9], gastric mucosa-associated lymphoid tissue lymphoma [10] and hepatocellular carcinoma [11], but a good prognosis in breast cancer [12]. This evidence concerns the gene FOXP1 and diffuse large B-cell lymphoma.